Protein Analytics Firm BioScale Raises $25M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein analytics firm BioScale said today it has raised $25 million in a recent financing round, to be used to commercialize the company's technology.

The round was led by new investor Morningside Venture, as well as existing investors New Science Ventures, WFD Ventures, F2 Ventures, and several individual investors.

BioScale will use the funds to expand manufacturing operations and sales of its ViBE protein analytics systems, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.